ArticleJournal of vascular surgery. Venous and lymphatic disorders2026
Outcomes of iliofemoral venous stenting in women with venous ulcers.
Article in Journal of vascular surgery. Venous and lymphatic disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07762222 (Outcomes of Iliac Vein Stenting With Dedicated Venous Stents in Treatment of Chronic Post-thrombotic Venous Ulcers), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Outcomes of Iliac Vein Stenting With Dedicated Venous Stents in Treatment of Chronic Post-thrombotic Venous Ulcers
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe efficacy of suprainguinal venous interventions in the management of venous ulceration, after the elimination of infrainguinal superficial venous reflux, is currently ill-defined. The purpose of this investigation was to assess the role of venous stenting and prior infrainguinal superficial vein interventions in the management of patients with nonhealing and/or recurrent venous ulcers.
methodsA retrospective cohort analysis of prospectively collected data from November 2019 to December 2024 on nonhealing or recurrent venous ulcer female patients treated with iliac vein stenting. Patient demographics, Revised Venous Clinical Severity Score, visual analog scale scores, number and types of superficial vein procedures in the index and contralateral limbs before stenting, ulcer size, duration, time to healing, reintervention rates, and types of reinterventions were assessed.
resultsFifty patients met the inclusion criteria. All were female with an average age of 66.7 ± 12.6 years and body mass index of 37.8 ± 8.2. The average Revised Venous Clinical Severity Score was 11.7 ± 4.8 on the left and 9.2 ± 4.3 on the right. Ulcers were in the left limb in 36 and the right limb in 14. The primary symptom on initial presentation was an active ulcer in 60% of patients. The remaining 40% presented with symptoms of chronic venous insufficiency secondary to symptomatic infrainguinal superficial vein reflux. In these patients, the time from initial patient encounter to the development of an ulcer was 617 ± 1353 days. Ulcer duration before diagnosis was 4.4 ± 4.2 months and 17 patients reported the ulcers were recurrent. Average ulcer size was 23.7 ± 37.2 cm
conclusionsVenous ulcer patients have chronic disease, with the majority reporting undergoing superficial interventions for 2 to 4 years before stenting. After iliac vein stenting, 60% of ulcers demonstrated complete ulcer healing, with 80% of those healed by 1 year. Ulcer healing is directly related to ulcer size and is associated with improved healing when infrainguinal superficial reflux is eliminated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.